BROOKLYN HOSPITAL CENTER, CLEARWAY HEALTH
PARTNER ON MEETING NEW HEPATITIS SCREENING RULES
DOWNTOWN BROOKLYN – THE BROOKLYN HOSPITAL CENTER HAS PARTNERED WITH CLEARWAY HEALTH to comply with the State Department of Health’s new requirements on Hepatitis C screenings. Their partnership involves developing a screening and treatment program through their specialty pharmacy that will launch in May. The new program at The Brooklyn Hospital Center included improved testing protocols, clinical workflows, patient education, and treatment plans for the emergency department, primary care, and maternal and fetal medicine. TBHC and Clearway also emphasize the importance of providing patients with getting the care and administrative help they need in obtaining prior authorizations from the patient’s health plan, finding vouchers and coupons, and ensuring patients comply with their medications.
HCV treatment requires specialty medication, and patients often encounter affordability obstacles with the specialty medications that HCV treatment requires. In some cases, patients’ health plans excludes these medications from coverage tiers or assign high co-pays.
